Proteogenomic analysis of air-pollution-associated lung cancer reveals prevention and therapeutic opportunities.

Honglei Zhang; Chao Liu; Shuting Wang; Qing Wang; Xu Feng; Huawei Jiang; Li Xiao; Chao Luo; Lu Zhang; Fei Hou; Minjun Zhou; Zhiyong Deng; Heng Li; Yong Zhang; Xiaosan Su; Gaofeng Li

Air pollution significantly impacts lung cancer progression, but there is a lack of a comprehensive molecular characterization of clinical samples associated with air pollution. Here, we performed a proteogenomic analysis of lung adenocarcinoma (LUAD) in 169 female never-smokers from the Xuanwei area (XWLC cohort), where coal smoke is the primary contributor to the high lung cancer incidence. Genomic mutation analysis revealed XWLC as a distinct subtype of LUAD separate from cases associated with smoking or endogenous factors. Mutational signature analysis suggested that Benzo[a]pyrene (BaP) is the major risk factor in XWLC. The BaP-induced mutation hotspot, EGFR-G719X, was present in 20% of XWLC which endowed XWLC with elevated MAPK pathway activations and worse outcomes compared to common EGFR mutations. Multi-omics clustering of XWLC identified four clinically relevant subtypes. These subgroups exhibited distinct features in biological processes, genetic alterations, metabolism demands, immune landscape, and radiomic features. Finally, MAD1 and TPRN were identified as novel potential therapeutic targets in XWLC. Our study provides a valuable resource for researchers and clinicians to explore prevention and treatment strategies for air-pollution-associated lung cancers.

LUNG cancer; GENOMICS; RESEARCH personnel; CANCER invasiveness; CANCER prevention; AIR pollution

eLife, 2024, p1

2050-084X

Academic Journal

10.7554/eLife.95453